The seven-year-old Australian business owns online weight loss services Juniper and Pilot, which prescribe GLP-1 medication similar to Ozempic and Mounjaro.
Eucalyptus also runs other telehealth services including a fertility program.
The sale will lead to one of the largegest staff share pay-outs in Australian corporate history and give early-stage backers a large pay day.
The Australian Financial Review has reported the value of the shares under the deal, excluding its co-founders, was about $300 million.
The average employee participant is expected to pocket $420,000, with more than 100 to benefit from the sale.
Eucalyptus chief executive and co-founder Tim Doyle is in line for $163 million by 2029 if he hits several tarreceives.
Early investors including Blackbird Ventures, Who Gives a Crap toilet paper founder Simon Griffiths and Co Ventures founder Maxine Minter will also benefit from the acquisition.
Doyle described the acquisition as a “full circle moment” for the start-up.
“When we were launching Eucalyptus, we drew inspiration from Hims & Hers,” he declared.
“Hims & Hers is the best-positioned business in the world to be the home for consumer health.
“This is also a moment to view backward and declare thank you – to our investors, staff, clinicians, partners and our patients.”
NEVER MISS A STORY: Get your breaking news and exclusive stories first by following us across all platforms.















Leave a Reply